Analysis of 42 cases of childhood superior vena cava syndrome associated with mediastinal malignancy

Objective: To summarize the clinical features, management and outcome of superior vena cava syndrome (SVCS) associated with mediastinal malignancy in children. Methods: Clinical data of 42 children of SVSC associated with mediastinal malignancy in Shanghai Children's Medical Center from January...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 60(2022), 10 vom: 02. Okt., Seite 1026-1030
1. Verfasser: Yang, Q S (VerfasserIn)
Weitere Verfasser: Han, Y L, Cai, J Y, Gu, S, Bai, J, Ren, H, Xu, M, Zhang, J, Zhang, A A, Su, M, Pan, C, Wang, Y, Tang, J Y, Gao, Y J
Format: Online-Aufsatz
Sprache:Chinese
Veröffentlicht: 2022
Zugriff auf das übergeordnete Werk:Zhonghua er ke za zhi = Chinese journal of pediatrics
Schlagworte:Journal Article
LEADER 01000naa a22002652 4500
001 NLM347231292
003 DE-627
005 20231226033339.0
007 cr uuu---uuuuu
008 231226s2022 xx |||||o 00| ||chi c
024 7 |a 10.3760/cma.j.cn112140-20220323-00239  |2 doi 
028 5 2 |a pubmed24n1157.xml 
035 |a (DE-627)NLM347231292 
035 |a (NLM)36207849 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Yang, Q S  |e verfasserin  |4 aut 
245 1 0 |a Analysis of 42 cases of childhood superior vena cava syndrome associated with mediastinal malignancy 
264 1 |c 2022 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 11.10.2022 
500 |a Date Revised 11.10.2022 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Objective: To summarize the clinical features, management and outcome of superior vena cava syndrome (SVCS) associated with mediastinal malignancy in children. Methods: Clinical data of 42 children of SVSC associated with mediastinal malignancy in Shanghai Children's Medical Center from January 2015 to December 2021 were collected and analyzed retrospectively. The clinical manifestations, pathological diagnosis, disease diagnosis process, and prognosis were summarized. Results: Among 42 children of SVCS associated with mediastinal malignancy, there were 31 males and 11 females. The age at diagnosis was 8.5 (1.9, 14.9) years. Cough and wheezing (33 cases, 79%), orthopnea (19 cases, 45%) and facial edema (18 cases, 43%) occurred most commonly. T-cell lymphoblastic lymphoma (T-LBL) was the most frequent pathological diagnosis (25 cases, 60%), followed by T-cell acute lymphoblastic leukemia (T-ALL) (7 cases, 17%), anaplastic large cell lymphoma (4 cases, 10%) and diffuse large B-cell lymphoma (2 cases, 5%), peripheral T-lymphoma, Hodgkin lymphoma, Ewing's sarcoma and germ cell tumor (1 case each). Pathological diagnosis was confirmed by bone marrow aspiration or thoracentesis in 14 cases, peripheral lymph node biopsy in 6 cases, and mediastinal biopsy in 22 cases. Twenty-seven cases (64%) had local anesthesia. Respiratory complications due to mediastinal mass developed in 3 of 15 cases who received general anesthesia. Of the 42 cases, 27 cases had sustained remission, 1 case survived with second-line therapy after recurrence, and 14 cases died (2 cases died of perioperative complications and 12 cases died of recurrence or progression of primary disease). The follow-up time was 36.7 (1.2, 76.1) months for 27 cases in continuous complete remission. The 3-year overall survival (OS) and events free survival (EFS) rates of 42 children were 59% (95%CI 44%-79%) and 58% (95%CI 44%-77%) respectively. Conclusions: SVCS associated with mediastinal malignancy in children is a life-threatening tumor emergency with high mortality. The most common primary disease is T-LBL. The most common clinical symptoms and signs are cough, wheezing, orthopnea and facial edema. Clinical management should be based on the premise of stable critical condition and confirm the pathological diagnosis through minimal invasive operation 
650 4 |a Journal Article 
700 1 |a Han, Y L  |e verfasserin  |4 aut 
700 1 |a Cai, J Y  |e verfasserin  |4 aut 
700 1 |a Gu, S  |e verfasserin  |4 aut 
700 1 |a Bai, J  |e verfasserin  |4 aut 
700 1 |a Ren, H  |e verfasserin  |4 aut 
700 1 |a Xu, M  |e verfasserin  |4 aut 
700 1 |a Zhang, J  |e verfasserin  |4 aut 
700 1 |a Zhang, A A  |e verfasserin  |4 aut 
700 1 |a Su, M  |e verfasserin  |4 aut 
700 1 |a Pan, C  |e verfasserin  |4 aut 
700 1 |a Wang, Y  |e verfasserin  |4 aut 
700 1 |a Tang, J Y  |e verfasserin  |4 aut 
700 1 |a Gao, Y J  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhonghua er ke za zhi = Chinese journal of pediatrics  |d 1960  |g 60(2022), 10 vom: 02. Okt., Seite 1026-1030  |w (DE-627)NLM136249191  |x 0578-1310  |7 nnns 
773 1 8 |g volume:60  |g year:2022  |g number:10  |g day:02  |g month:10  |g pages:1026-1030 
856 4 0 |u http://dx.doi.org/10.3760/cma.j.cn112140-20220323-00239  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_61 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_244 
912 |a GBV_ILN_285 
912 |a GBV_ILN_294 
912 |a GBV_ILN_350 
912 |a GBV_ILN_665 
912 |a GBV_ILN_813 
951 |a AR 
952 |d 60  |j 2022  |e 10  |b 02  |c 10  |h 1026-1030